abstract |
The invention relates to novel isoindoline or isoquinoline compounds, a method for their preparation and pharmaceutical compositions containing them. The compounds of the present invention are new and have valuable pharmacological properties in the field of apoptosis and carcinogenesis. The invention more particularly relates to compounds of formula (I), their enantiomers and diastereoisomers and addition salts with a pharmaceutically acceptable acid or base: |